VIENNALAB - Established innovations in diagnostics

HLA-B27 is a genetic risk factor for seronegative spondyloarthropathies, such as ankylosing spondylitis, reactive arthritis, juvenile rheumatoid arthritis and anterior uveitis. ViennaLab HLA-B27 assays detect all disease-relevant HLA-B27 subtypes.

HLA-B27 is a genetic risk factor for seronegative spondyloarthropathies,

such as ankylosing spondylitis, reactive arthritis, juvenile rheumatoid arthritis

and anterior uveitis.

ViennaLab HLA-B27 assays detect all disease-relevant HLA-B27 subtypes.

HLA-B27

  • Ankylosing spondylitis (Morbus Bechterew) is the most prevalent spondyloarthropathy affecting 0.1 - 1% of the general population
  • Symptoms at the onset of the disease are usually nonspecific, posing difficulties for a firm diagnosis
  • Differentiating between HLA-B27 positive and negative patients is an important parameter for diagnosing spondyloarthropathies
  • Early and adequate treatment ameliorates the course of the disease

Product Details

HLA-B27 StripAssay® ref4-320
HLA-B27 RealFast™ Assay ref7-620 7-623